This site uses cookies to enhance your experience. By continuing to browse you accept our Cookie Policy.
Close-up of syringe and vial used for mRNA therapy

INSIGHTS

30 Mar 2026

Personalized, Persistent, Powerful: mRNA Takes On Breast Cancer

BioNTech's personalized mRNA vaccine kept 11 of 14 aggressive breast cancer patients relapse-free for up to six years

Medical professional preparing vaccine dose from vial using syringe in clinical setting

INNOVATION

25 Mar 2026

One Shot, Six Years, No Cancer

A personalized mRNA vaccine kept 11 of 14 breast cancer patients relapse-free for six years, no boosters needed

Exterior of Queen Elizabeth Hospital Birmingham with A&E entrance and police vehicle

MARKET TRENDS

19 Mar 2026

A Vaccine Tailored to You? Birmingham Tests It

UK hospital leads Europe’s first personalised mRNA trial for pancreatic cancer, aiming to stop relapse after surgery

Medical professional drawing liquid from vial into syringe

INSIGHTS

16 Mar 2026

Europe Ranks Third in Global mRNA Race

A new study of 557 trials shows Europe is a primary hub for mRNA innovation as the field pivots from COVID-19 to oncology and rare disease...

Healthcare professional administering vaccine injection to masked patient

PARTNERSHIPS

10 Mar 2026

Can mRNA Conquer TB and Malaria? Germany Is Trying

Ethris and DZIF partner to develop next-gen mRNA vaccines for TB, malaria, hepatitis and more using advanced LNP platforms

Vaccine vial and injection syringe silhouette with blurred biotech branding

INNOVATION

20 Feb 2026

The Next mRNA Breakthrough May Be in the Packaging

Early NeoVac data hint that redesigned lipid nanoparticles could make mRNA vaccines safer for repeat use

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.